A Study of GR1802 Injection in Patients With Seasonal Allergic Rhinitis.

Allergic rhinitis (AR) is a non-infectious chronic inflammatory disease of the nasal mucosa mainly mediated by immunoglobulin E after exposure to allergens in atopic individuals. The typical symptoms of AR are paroxysmal sneezing, watery rhinorrhea, itching, and nasal congestion, which may be accompanied by ocular symptoms, including eye itching, tearing, redness, and burning sensation, which are more common in patients with hay fever allergies.

NCT Number	NCT07199257
Lead Sponsor	Genrix (Shanghai) Biopharmaceutical Co., Ltd.
Conditions	Allergic Rhinitis, Seasonal
Enrollment	144 participants
Start Date	2025-09-25
Primary Completion	2027-05-15 (estimated)
Study Completion	2027-07-31 (estimated)
Updated on ClinicalTrials.gov	2025-09-30